Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 2
2014 1
2015 1
2016 6
2017 2
2018 7
2019 2
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Key Enabling Technologies for Point-of-Care Diagnostics.
Primiceri E, Chiriacò MS, Notarangelo FM, Crocamo A, Ardissino D, Cereda M, Bramanti AP, Bianchessi MA, Giannelli G, Maruccio G. Primiceri E, et al. Among authors: notarangelo fm. Sensors (Basel). 2018 Oct 24;18(11):3607. doi: 10.3390/s18113607. Sensors (Basel). 2018. PMID: 30355989 Free PMC article. Review.
Exercise Your Kynurenines to Fight Depression.
Notarangelo FM, Pocivavsek A, Schwarcz R. Notarangelo FM, et al. Trends Neurosci. 2018 Aug;41(8):491-493. doi: 10.1016/j.tins.2018.05.010. Trends Neurosci. 2018. PMID: 30053952
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.
Hare SM, Adhikari BM, Mo C, Chen S, Wijtenburg SA, Seneviratne C, Kane-Gerard S, Sathyasaikumar KV, Notarangelo FM, Schwarcz R, Kelly DL, Rowland LM, Buchanan RW. Hare SM, et al. Among authors: notarangelo fm. Neuropsychopharmacology. 2023 Oct;48(11):1594-1601. doi: 10.1038/s41386-023-01587-3. Epub 2023 Apr 28. Neuropsychopharmacology. 2023. PMID: 37118058 Clinical Trial.
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.
Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW, Louie JY, Wu T, Scearce-Levie K, Patrick C, Adame A, Giorgini F, Moussaoui S, Laue G, Rassoulpour A, Flik G, Huang Y, Muchowski JM, Masliah E, Schwarcz R, Muchowski PJ. Zwilling D, et al. Among authors: notarangelo fm. Cell. 2011 Jun 10;145(6):863-74. doi: 10.1016/j.cell.2011.05.020. Cell. 2011. PMID: 21640374 Free PMC article.
Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.
Chiappelli J, Notarangelo FM, Pocivavsek A, Thomas MAR, Rowland LM, Schwarcz R, Hong LE. Chiappelli J, et al. Among authors: notarangelo fm. Neuropsychopharmacology. 2018 Jul;43(8):1675-1680. doi: 10.1038/s41386-018-0038-4. Epub 2018 Feb 27. Neuropsychopharmacology. 2018. PMID: 29520060 Free PMC article.
Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.
Chiappelli J, Rowland LM, Notarangelo FM, Wijtenburg SA, Thomas MAR, Pocivavsek A, Jones A, Wisner K, Kochunov P, Schwarcz R, Hong LE. Chiappelli J, et al. Among authors: notarangelo fm. Neuropsychopharmacology. 2018 Jul;43(8):1706-1711. doi: 10.1038/s41386-018-0072-2. Epub 2018 Apr 18. Neuropsychopharmacology. 2018. PMID: 29728648 Free PMC article.
30 results